A detailed history of Moseley Investment Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Moseley Investment Management Inc holds 2,060 shares of NVO stock, worth $218,627. This represents 0.1% of its overall portfolio holdings.

Number of Shares
2,060
Previous 2,060 -0.0%
Holding current value
$218,627
Previous $294,000 16.67%
% of portfolio
0.1%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 04, 2024

SELL
$102.11 - $135.92 $30,633 - $40,775
-300 Reduced 12.71%
2,060 $264,000
Q4 2023

Jan 25, 2024

BUY
$87.78 - $105.45 $207,160 - $248,862
2,360 New
2,360 $244,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Moseley Investment Management Inc Portfolio

Follow Moseley Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moseley Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Moseley Investment Management Inc with notifications on news.